Cargando…
Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor
BACKGROUND: Autoantibodies specific to the angiotensin II type I receptor (anti-AT(1)-AR) have been implicated in the pathology of congestive heart failure (CHF). Anti-AT(1)-AR may be associated with left ventricular function in CHF patients treated with perindopril. METHODS: Synthetic angiotensin I...
Autores principales: | Du, Qian, Wu, Jinling, Wang, Hua, Wang, Xin, Xu, Lin, Zhang, Zhiyong, Liu, Jiamei, Zhang, Juan, Chen, Jin, Hakonarson, Hakon, Hu, Aihua, Zhang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816204/ https://www.ncbi.nlm.nih.gov/pubmed/24175973 http://dx.doi.org/10.1186/1471-2261-13-94 |
Ejemplares similares
-
Combination of angiotensin-(1–7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy
por: Hao, Panpan, et al.
Publicado: (2015) -
Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure
por: Sun, Yuxi, et al.
Publicado: (2021) -
Right Ventricle Remodelling in Left-Sided Heart Failure in Rats: The Role of Calcium Signalling
por: Paterek, Aleksandra, et al.
Publicado: (2022) -
Women had favourable reverse left ventricle remodelling after TAVR
por: Chen, Su‐Chan, et al.
Publicado: (2020) -
Engineering of MSCs sheet for the prevention of myocardial ischemia and for left ventricle remodeling
por: Chang, Dehua, et al.
Publicado: (2023)